These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relationships among morphine metabolism, pain and side effects during long-term treatment: an update. Andersen G; Christrup L; Sjøgren P J Pain Symptom Manage; 2003 Jan; 25(1):74-91. PubMed ID: 12565191 [TBL] [Abstract][Full Text] [Related]
3. Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration. Wolff T; Samuelsson H; Hedner T Pain; 1995 Aug; 62(2):147-154. PubMed ID: 8545139 [TBL] [Abstract][Full Text] [Related]
4. Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients. Wolff T; Samuelsson H; Hedner T Pain; 1996 Dec; 68(2-3):209-16. PubMed ID: 9121807 [TBL] [Abstract][Full Text] [Related]
5. Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat. Doyle HH; Murphy AZ Physiol Behav; 2018 Apr; 187():32-41. PubMed ID: 29199028 [TBL] [Abstract][Full Text] [Related]
6. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat. Van Crugten JT; Somogyi AA; Nation RL; Reynolds G Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis. Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468 [TBL] [Abstract][Full Text] [Related]
8. Randomized placebo-controlled trial of the activity of the morphine glucuronides. Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027 [TBL] [Abstract][Full Text] [Related]
10. Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranes. Löser SV; Meyer J; Freudenthaler S; Sattler M; Desel C; Meineke I; Gundert-Remy U Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):192-7. PubMed ID: 8857597 [TBL] [Abstract][Full Text] [Related]
11. Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain. Goucke RC; Hackett PL; Ilett KF Pain; 1994 Feb; 56(2):145-149. PubMed ID: 8008404 [TBL] [Abstract][Full Text] [Related]
12. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Qian-Ling G; Hedner J; Björkman R; Hedner T Pain; 1992 Feb; 48(2):249-255. PubMed ID: 1589243 [TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain. Quigley C; Joel S; Patel N; Baksh A; Slevin M Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries. Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627 [TBL] [Abstract][Full Text] [Related]
15. Effects of morphine glucuronides on the function of opioid receptors in human SK-N-SH cells. Baker L; Dye A; Ratka A Neurosci Lett; 2000 Mar; 281(1):1-4. PubMed ID: 10686401 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig. Milne RW; Jensen RH; Larsen C; Evans AM; Nation RL Pharm Res; 1997 Aug; 14(8):1014-8. PubMed ID: 9279882 [TBL] [Abstract][Full Text] [Related]
17. Modulation of metabolic effects of morphine-6-glucuronide by morphine-3-glucuronide. Hashiguchi Y; Molina PE; Abumrad NN Brain Res Bull; 1995; 38(4):325-9. PubMed ID: 8535854 [TBL] [Abstract][Full Text] [Related]
18. CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine. Samuelsson H; Hedner T; Venn R; Michalkiewicz A Pain; 1993 Feb; 52(2):179-185. PubMed ID: 8455965 [TBL] [Abstract][Full Text] [Related]
19. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories. Du X; Skopp G; Aderjan R Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341 [TBL] [Abstract][Full Text] [Related]
20. Influence of ranitidine on the morphine-3-glucuronide to morphine-6-glucuronide ratio after oral administration of morphine in humans. Aasmundstad TA; Størset P Hum Exp Toxicol; 1998 Jun; 17(6):347-52. PubMed ID: 9688360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]